Dr. Yuhchyau Chen
Claim this profileUniversity of Rochester
About Yuhchyau Chen
Education:
- MD from the University of Rochester School of Medicine and Dentistry, 1997.
Experience:
- Completed Residency in Internal Medicine at the University of Rochester Medical Center, 2000.
- Finished Fellowship in Hematology/Oncology at the University of Rochester Medical Center, 2003.
- Currently an Associate Professor of Medicine at the University of Rochester Medical Center, with a specialization in Hematology and Oncology.
Area of expertise
Lung Cancer
Yuhchyau Chen has run 9 trials for Lung Cancer. Some of their research focus areas include:
Prostate Cancer
Yuhchyau Chen has run 7 trials for Prostate Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Rochester
Highland Hospital
Clinical Trials Yuhchyau Chen is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting
1 award
Phase 2 & 3
21 criteria
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting
0 awards
Phase 2
More about Yuhchyau Chen
Clinical Trial Related
6 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 18 Active Clinical Trials
Treatments Yuhchyau Chen has experience with
- Radiation Therapy
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Paclitaxel
- Carboplatin
- Atezolizumab
Breakdown of trials Yuhchyau Chen has run
Lung Cancer
Prostate Cancer
Prostate Adenocarcinoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yuhchyau Chen specialize in?
Yuhchyau Chen focuses on Lung Cancer and Prostate Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Yuhchyau Chen currently recruiting for clinical trials?
Yes, Yuhchyau Chen is currently recruiting for 18 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Yuhchyau Chen has studied deeply?
Yes, Yuhchyau Chen has studied treatments such as Radiation Therapy, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Yuhchyau Chen?
Apply for one of the trials that Yuhchyau Chen is conducting.
What is the office address of Yuhchyau Chen?
The office of Yuhchyau Chen is located at: University of Rochester, Rochester, New York 14642 United States. This is the address for their practice at the University of Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.